Norman E. Rosenthal is an American psychiatrist and author, renowned for his groundbreaking work in identifying and describing Seasonal Affective Disorder (SAD). Born and educated in South Africa, he pursued his medical training in the United States, eventually establishing a private practice and conducting extensive research at the National Institute of Mental Health (NIMH) for over two decades. His research at NIMH focused on mood disorders, sleep patterns, and biological rhythms, leading to his pivotal description of SAD and the development of light therapy as a primary treatment. Rosenthal's contributions have significantly advanced the understanding and management of mood disorders influenced by seasonal changes. He has authored numerous books, including seminal works on SAD, as well as exploring topics such as Transcendental Meditation, post-traumatic stress disorder, and the therapeutic benefits of poetry. His prolific career includes over 300 scholarly publications and a lasting impact on psychiatric research and clinical practice.

Dr. Norman E. Rosenthal is widely recognized as the pioneer in the study of Seasonal Affective Disorder (SAD). His interest in the subject was sparked by his own observations of mood shifts correlating with seasonal changes, particularly after emigrating from the milder climate of Johannesburg to the northeastern United States. While training as a resident at the New York State Psychiatric Institute, he noted differences in his own energy and productivity between the longer days of summer and the shorter, darker days of winter. This personal observation, combined with a patient's report of seasonal mood fluctuations, led Rosenthal and his colleagues at NIMH to investigate further. In 1984, they published their findings, officially describing SAD and introducing light therapy as a novel and effective treatment for the condition. This work laid the foundation for a new understanding of mood disorders influenced by environmental light.

The cornerstone of Dr. Rosenthal's contribution to psychiatry is the development and popularization of light therapy for Seasonal Affective Disorder (SAD). Following initial observations and a successful case study, his team conducted formal research, culminating in the 1984 publication that defined SAD and validated phototherapy. Despite some ongoing debate among researchers, light therapy for SAD is now endorsed by major institutions like the National Institute of Mental Health, Mayo Clinic, and Cleveland Clinic, and is included in authoritative textbooks. Rosenthal's research extended beyond SAD, exploring related phenomena such as "reverse SAD" experienced in summer. He also developed the Seasonal Pattern Assessment Questionnaire, a widely used tool for identifying seasonality in individuals. His work has fundamentally changed how seasonal mood changes are understood and treated in clinical practice.

Beyond his work on SAD, Dr. Norman E. Rosenthal has explored various other therapeutic modalities and their potential benefits. He has authored books on the practice of Transcendental Meditation (TM), detailing its role in healing and transformation, and its potential application for patients suffering from post-traumatic stress disorder (PTSD). His research in this area included studies comparing TM with other therapeutic approaches for veterans with PTSD. Rosenthal also investigated the antidepressant effects of botulinum toxin (Botox) injections in the forehead muscles, collaborating with Eric Finzi. Furthermore, he has delved into the therapeutic power of poetry, authoring "Poetry RX" to highlight how poems can offer healing and joy. His broad range of interests reflects a comprehensive approach to mental well-being.